Skip to main content

Table 4 Age stratification analysis

From: Are gastrointestinal symptoms associated with higher risk of Mortality in COVID-19 patients? A systematic review and meta-analysis

Age stratification

No. of studies

OR and 95% CI of GI symptom for mortality

P value of OR

No. of studies that average age: GI group >non GI group

No. of studies that average age: GI group <non-GI group

0–39

3

2.36 [0.88; 6.33]

0.088

NA

NA

40–49

8

2.22 [0.96; 5.11]

0.061

5 (83.3%)

1 (16.7%)

50–59

15

1.09 [0.85; 1.40]

0.517

3 (33.3%)

6 (66.7%)

60–69

18

0.71 [0.54; 0.95]

0.02

0 (0%)

6 (100%)

70~

7

0.40 [0.21; 0.76]

0.006

0

1 (100%)

  1. OR, odds ratio; CI, confidence interval; GI, gastrointestinal; NA, data are not available because the studies in the subgroups did not report the age information of patients with/without GI symptoms